(© Maridav - stock.adobe.com)
OSLO, Norway — As debate continues over the effectiveness of face masks, a large-scale study from the Norwegian Institute of Public Health delivers a clear verdict: masks work. The research shows that wearing surgical face masks in public spaces can lead to a substantial reduction in respiratory infections.
The study, conducted in Norway between February and April 2023, involved 4,575 adult participants with an average age of 51, of whom 61% were women. Half of the participants were asked to wear surgical face masks in public spaces for two weeks, while the other half went about their daily lives without masks. The results were striking: those who wore masks experienced fewer respiratory symptoms compared to those who didn’t.
This research provides some of the strongest evidence to date supporting the use of face masks as a personal protective measure against respiratory infections. While previous studies have hinted at the benefits of mask-wearing, this large-scale, randomized trial offers more definitive proof.
Specifically, 8.9% of participants in the mask-wearing group reported respiratory symptoms consistent with infection, compared to 12.2% in the control group. This represents a 3.2% reduction in absolute risk, equivalent to about 3,300 fewer infections per 100,000 people – a substantial reduction that could have significant implications for public health.
The timing of the study, which is now published in The BMJ, is particularly interesting. Conducted during Norway’s typical flu season, it offers insights into the effectiveness of masks in a more “normal” respiratory illness environment. This suggests that mask-wearing could be a valuable tool not just for extraordinary pandemic situations, but also for managing seasonal illness outbreaks.
One of the most intriguing aspects of the study is its focus on self-reported symptoms rather than laboratory-confirmed infections. Participants were asked to report any symptoms consistent with a respiratory infection, defined as fever and one respiratory symptom (such as stuffy or runny nose, sore throat, coughing, sneezing, heavy breathing), or one respiratory symptom and at least two other symptoms (like body ache, muscular pain, fatigue, reduced appetite, stomach pain, headache, loss of smell).
It’s important to note that the study focused on surgical masks, not cloth masks or N95 respirators. Surgical masks are widely available and relatively inexpensive, making them a practical option for widespread use. The researchers chose to study these masks as they were recommended by the World Health Organization during the COVID-19 pandemic.
However, the study also highlighted some challenges associated with mask-wearing. Of 155 participants who reported adverse effects, 80 mentioned receiving unpleasant comments from others when wearing a face mask in public spaces and feeling “silly” being the only one wearing a mask. Another 40 participants said wearing the mask was uncomfortable or tiring due to breathing difficulties, fogging of glasses, and poor fit.
Despite these challenges, the researchers conclude that wearing a face mask is a simple, relatively low-cost, and generally well-tolerated intervention. They suggest it is one of several public health and social measures that may be worth considering for reducing the spread of respiratory infections.
Paper Summary
Methodology
The study was designed as a randomized controlled trial, often considered the gold standard in medical research. Over 4,500 adult participants in Norway were randomly assigned to either wear surgical face masks in public spaces for 14 days or to go about their normal routines without masks. Participants completed questionnaires at the beginning and end of the study period, reporting on their demographics, mask-wearing habits, and any respiratory symptoms they experienced. The researchers also collected data on COVID-19 infections from Norway’s national registry.
Results
The primary finding was that 8.9% of participants in the mask-wearing group reported respiratory symptoms consistent with infection, compared to 12.2% in the control group. This represents a 29% reduction in risk for those wearing masks. The absolute risk difference was 3.2%, meaning that for every 100 people who wore masks, about 3 fewer people developed respiratory symptoms. There was no significant difference in confirmed COVID-19 cases between the two groups, likely due to the low overall number of cases during the study period.
Limitations
The study had several limitations. First, there was a higher rate of missing data in the mask-wearing group, which could potentially bias the results. The researchers used statistical methods to account for this, but it remains a concern. Second, the primary outcome was self-reported symptoms rather than confirmed infections, which could be subject to reporting bias. Third, the study was conducted over a relatively short period (14 days) and during a specific season, so the results may not apply to longer-term mask use or different times of the year. Finally, as participants couldn’t be blinded to their group assignment, this awareness could have influenced their behavior or symptom reporting.
Discussion and Takeaways
The researchers emphasize that their findings provide real-world evidence of the effectiveness of surgical face masks in reducing respiratory symptoms. They suggest that mask-wearing could be a valuable tool for managing both seasonal respiratory illnesses and future pandemics. However, they also note the need for further research, particularly on the effectiveness of masks for vulnerable populations and the environmental impact of widespread mask use. The study underscores the importance of considering masks as one of several public health measures that could help reduce the spread of respiratory infections.
Funding and Disclosures
The study was funded by the Centre for Epidemic Interventions Research at the Norwegian Institute of Public Health. The authors declared no significant competing interests, although one author had received financial support from the World Health Organization to attend meetings, and another was named as an inventor on a patent application related to vaccine development. These disclosures are important for transparency but do not necessarily impact the validity of the study’s findings.
“Despite these challenges, the researchers conclude that wearing a face mask is a simple, relatively low-cost, and generally well-tolerated intervention”…. I would disagree vehemently with this conclusion. Wearing a mask is a serious interference and very uncomfortable to wear for any length of time. I’m not sure even a 3% difference in infection rates (as noted in the article) is worth the hassle and inconvenience. Plus the so called “infections” were not even clinically confirmed, so who knows what most of them even were? This study is seriously flawed and the conclusions drawn are suspect.
not a very good study , small sample des not pass the smell test